From Frantic SOS Calls to No Buyers, Drugmakers Struggle With Excess Stock of Covid Drugs as Cases Wane

​ Favipiravir and Remdesivir became the most sought-after experimental drugs for the treatment of Covid-19 patients and till August 2021, the sales of these drugs had gone up by over 2,000 per cent and 700 per cent since their launch in June 2020